Jeannette Lechner‐Scott

Author

Also Known As

Bassem Yamout, Clare L. Fraser, David Williams, F Granella, Ingrid Kockum, Izanne Roos, J Lechner-Scott, J. Lechner-Scott, J. Lechner‐Scott, Jeanette Lechner-Scott

495

Publications

16.5K

Citations

H-Index

144

Concepts

All Affiliations

John Hunter Hospital The University of Melbourne The Royal Melbourne Hospital University of Newcastle Australia Hunter Medical Research Institute

About

Jeannette Lechner‐Scott is an author at John Hunter Hospital specializing in multiple sclerosis, medicine, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	39	2.8K
2	Public Health	11	11	453
3	Health Sciences	4	4	982
4	Engineering	3	3	284
5	Nursing	1	1	40

Jeannette Lechner‐Scott

159

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination Sudarshini Ramanathan, Shekeeb S. Mohammad, Esther Tantsis, Journal of Neurology Neurosurgery & Psychiatry	2017	548
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis J William L Brown, Alasdair Coles, Dana Horáková, JAMA	2019	511
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue Ulrich Roelcke, Ludwig Kappos, Jeannette Lechner‐Scott, Neurology Fatigue SeverityNeurological DisorderFrontal CortexMetabolic SyndromeMultiple Sclerosis Patients	1997	472
Defining secondary progressive multiple sclerosis Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Brain Neurological DisorderDisabilityClinical NeurologyNeurological ProgressNeurological Rehabilitation	2016	401
MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood Mathew Cox, Murray J. Cairns, Kaushal Gandhi, PLoS ONE Ms Whole BloodEngineeringT-regulatory CellImmunologyImmune System	2010	244
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis María Trojano, Guglielmo Lucchese, Giusi Graziano, PLoS ONE	2012	234
Defining reliable disability outcomes in multiple sclerosis Tomáš Kalinčík, Gary Cutter, Tim Spelman, Brain	2015	223
Locus for severity implicates CNS resilience in progression of multiple sclerosis Adil Harroud, Pernilla Stridh, Jacob L. McCauley, Nature Neurodegenerative DiseasesNeurological DisorderNeurological ProgressNeurologyNeuroscience	2023	202
Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis Vilija Jokubaitis, Tim Spelman, Tomáš Kalinčík, Annals of Neurology	2016	192
The COVID-19 pandemic and the use of MS disease-modifying therapies Gavin Giovannoni, Chris Hawkes, Jeannette Lechner‐Scott, Multiple Sclerosis and Related Disorders	2020	190

Page 1